HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R Leclercq Selected Research

quinupristin-dalfopristin (Synercid)

4/2001Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.
5/2000Characterization of isolates associated with emerging resistance to quinupristin/dalfopristin (Synercid) during a worldwide clinical program.
5/2000Influence of resistance to streptogramin A type antibiotics on the activity of quinupristin-dalfopristin in vitro and in experimental endocarditis due to Staphylococcus aureus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R Leclercq Research Topics

Disease

11Infections
06/2011 - 01/2000
6Respiratory Tract Infections (Respiratory Tract Infection)
07/2015 - 01/2001
3Endocarditis
11/2003 - 05/2000
2Cross Infection (Nosocomial Infection)
03/2011 - 04/2008
2Pneumonia (Pneumonitis)
11/2003 - 08/2001
1Pharyngitis (Sore Throat)
07/2015
1Neutropenia
02/2014
1Communicable Diseases (Infectious Diseases)
12/2012
1Necrotizing Pneumonia
09/2010
1Chlamydia Infections
04/2009
1Leg Ulcer
06/2008
1Neoplasms (Cancer)
03/2008
1Meningitis
11/2003
1Staphylococcal Infections
09/2003
1Adenocarcinoma of Lung
02/2001
1Body Weight (Weight, Body)
05/2000
1Soft Tissue Infections
01/2000

Drug/Important Bio-Agent (IBA)

11Anti-Bacterial Agents (Antibiotics)IBA
02/2014 - 01/2000
3PristinamycinIBA
08/2010 - 09/2003
3MacrolidesIBA
08/2005 - 04/2001
3KetolidesIBA
01/2004 - 09/2001
3quinupristin-dalfopristin (Synercid)FDA Link
04/2001 - 05/2000
2GlycopeptidesIBA
02/2014 - 09/2010
2Methicillin (Metin)FDA Link
09/2010 - 06/2008
2VancomycinFDA LinkGeneric
09/2010 - 05/2000
2CoagulaseIBA
09/2010 - 10/2001
2beta-LactamsIBA
08/2005 - 08/2005
2telithromycin (Ketek)FDA Link
02/2002 - 09/2001
2Rifampin (Rifampicin)FDA LinkGeneric
08/2001 - 04/2001
1Josamycin (EN 141)IBA
07/2015
1Enterotoxins (Enterotoxin)IBA
06/2011
1Staphylococcal enterotoxin FIBA
06/2011
1ExfoliatinsIBA
06/2011
1Panton-Valentine leukocidinIBA
06/2011
1ceftobiproleIBA
03/2011
1Oxacillin (Prostaphlin)FDA LinkGeneric
09/2010
1Leukocidins (Leukocidin)IBA
09/2010
1TeicoplaninIBA
09/2010
1Hepatitis C AntibodiesIBA
04/2009
1PowdersIBA
08/2008
1CatalaseIBA
06/2008
1Tigecycline (Tygacil)FDA Link
04/2008
1Adrenal Cortex Hormones (Corticosteroids)IBA
11/2003
1Moxifloxacin (Avelox)FDA Link
10/2003
1Clindamycin (Cleocin)FDA LinkGeneric
09/2001
1Erythromycin (Erycette)FDA LinkGeneric
08/2001
1StreptograminsIBA
04/2001
1Dihydrotachysterol (AT 10)IBA
02/2001
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
05/2000
1Streptogramin AIBA
05/2000
1Fusidic Acid (Fucithalmic)IBA
01/2000

Therapy/Procedure

2Therapeutics
09/2001 - 01/2001